IABG Group sells EXTEDO GmbH to Bertelsmann Investments

Ottobrunn / Gütersloh, February 15, 2024 - The IABG Group is selling the pharma tech company EXTEDO to Bertelsmann Investments (BI). EXTEDO, based in the greater Munich area, was founded in 2003 under the name IABG-Life Sciences Solutions GmbH within the IABG Group to support companies in the pharmaceutical industry in complying with regulatory requirements within the drug and medical device lifecycle. Today, EXTEDO is a leading provider of software solutions and services in the field of regulatory information management, serving both industrial companies and public authorities as customers.

Prof. Dr.-Ing. Rudolf F. Schwarz, Managing Partner of IABG, says: "I am delighted that with Bertelsmann Investments we have found a buyer who will expand and further develop EXTEDO as an international player in the pharma tech market in the long term. I am convinced that the first synergy effects will quickly materialize. At the same time, I would like to thank the EXTEDO management and all employees for more than two decades of excellent work in the IABG Group."

About EXTEDO 
EXTEDO is a leading provider of software solutions and services for life sciences organizations in the field of Regulatory Information Management (RIM). EXTEDO's holistic platform solution, EXTEDOpulse, enables companies and authorities to comply with regulations and efficiently manage information along the entire drug and medical device lifecycle. The product portfolio combines innovation and compliance as well as quality and user-friendliness. EXTEDO optimizes regulatory business processes in areas such as document management, product registration, marketing authorization management and drug safety. 
With around 1000 customers in over 65 countries, including more than 35 regulatory authorities, EXTEDO has played a key role in advancing regulatory standards for over 25 years. 
For more information, please visit EXTEDO's website www.extedo.com.
 

Contact